Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Hodgkin's Disease

Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft

Bone Marrow Transplantation volume 26, pages 1185–1191 (2000)Cite this article

Abstract

Despite detailed evaluation of disease-associated prognostic factors, little is known about the impact of overweight in autograft programs for non-Hodgkin's lymphoma (NHL) patients. In order to address this issue, 121 NHL patients were retrospectively evaluated. They had been upfront (92 patients) or in relapse (29 patients) and received high-dose sequential (HDS) chemotherapy including peripheral blood progenitor cell (PBPC) autograft. Body mass index (BMI) was calculated as weight in kilograms divided by the square of the height in meters; overweight was defined as BMI ⩾28. Univariate and multivariate analyses were used to determine the prognostic implication of overweight and other known prognostic indicators on overall (OS) and event-free (EFS) survival for the entire group and overweight and non-overweight (reference) subgroups. With a median follow-up of 3 years, the estimated 5-year OS and EFS for the entire group were 58% and 49%, respectively. Twenty-eight patients (23%) had BMI ⩾28. Their median OS and EFS were 2.2 and 1.4 years, respectively, whereas median OS and EFS for the reference group have not been reached, with a 5-year projection of 65 and 55%, respectively (P < 0.002). On multivariate analysis, the risk of death among overweight patients was 2.9 (CI, 1.3–6.2) times that of the reference group; using EFS as the end point, a similar association between overweight and survival was observed. In conclusion, in high-risk NHL patients undergoing intensive chemotherapy and PBPC autografting overweight is associated with a poorer outcome. Bone Marrow Transplantation (2000) 26, 1185–1191.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Philip T, Guglielmi C, Hagenbeck A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma New Engl J Med 1995 333: 1540–1545

    Article  CAS  Google Scholar 

  2. Gribben JG, Freedman AS, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma New Engl J Med 1991 325: 1525–1533

    Article  CAS  Google Scholar 

  3. Rohatiner AZS, Freedman AS, Nadler L et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma Ann Oncol 1994 5: (Suppl. 2) 143–146

    Article  Google Scholar 

  4. Gianni AM, Siena S, Bregni M et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating hematopoietic stem cells for autotransplantation Lancet 1989 ii: 580–585

    Article  Google Scholar 

  5. Pettengell R, Testa NG, Swindell R et al. Transplantation potential of hematopoietic cell released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma Blood 1993 82: 2239–2248

    CAS  PubMed  Google Scholar 

  6. Tarella C, Gavarotti P, Caracciolo D et al. Haematological support of high-dose sequential chemotherapy: clinical evidence for reduction of toxicity and high response rate in poor risk lymphomas Ann Oncol 1995 6: (Suppl. 4) 3–8

    Article  Google Scholar 

  7. Pettengell R, Radford JA, Mogenstern GR et al. Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin'slymphoma J Clin Oncol 1996 14: 586–592

    Article  CAS  Google Scholar 

  8. Gianni AM, Bregni M, Siena S et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma New Engl J Med 1997 336: 1290–1295

    Article  CAS  Google Scholar 

  9. Cortelazzo S, Rossi A, Viero P et al. BEAM chemotherapy and autologous hemopoietic progenitor cell transplantation as front-line therapy for high-risk patients with diffuse large cell lymphoma Br J Haematol 1997 99: 379–385

    Article  CAS  Google Scholar 

  10. Bastion Y, Brice P, Haioun C et al. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma Blood 1995 86: 3257–3262

    CAS  PubMed  Google Scholar 

  11. Haas R, Moos M, Mohle R et al. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma Bone Marrow Transplant 1996 17: 149–155

    CAS  PubMed  Google Scholar 

  12. Freedman AS, Gribben JG, Neuberg D et al. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission Blood 1996 88: 2780–2786

    CAS  PubMed  Google Scholar 

  13. Bierman PJ, Vose JM, Anderson JR et al. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma J Clin Oncol 1997 15: 445–450

    Article  CAS  Google Scholar 

  14. Corradini P, Astolfi M, Cherasco C et al. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting Blood 1997 89: 724–731

    CAS  PubMed  Google Scholar 

  15. Coiffier B, Gisselbrecht C, Vose JM et al. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognotic index that could identify patient requiring a more intensive therapy J Clin Oncol 1991 9: 211–219

    Article  CAS  Google Scholar 

  16. The International non-Hodgkin's Lymphoma Prognostic Factor Project . A predictive model for aggressive non-Hodgkin's lymphoma New Engl J Med 1993 329: 987–994

    Article  Google Scholar 

  17. Lopez-Guillermo A, Montserrat E, Bosch F et al. Applicability of the international index for aggressive lymphomas to patients with low-grade lymphoma J Clin Oncol 1994 12: 1343–1348

    Article  CAS  Google Scholar 

  18. Senie RT, Rosen PP, Rhodes P et al. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival Ann Intern Med 1992 116: 26–32

    Article  CAS  Google Scholar 

  19. Bastarrachea J, Hortobagyi GN, Smith TL et al. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer Ann Intern Med 1994 120: 18–25

    Article  CAS  Google Scholar 

  20. Fleming DR, Rayens MK, Garrison J . Impact of obesity on allogeneic stem cell transplant patients: a matched case-controlled study Am J Med 1997 102: 265–268

    Article  CAS  Google Scholar 

  21. Hansen J, Gooley TA, Martin PJ et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia New Engl J Med 1998 338: 962–968

    Article  CAS  Google Scholar 

  22. Keys A, Fidanza F, Karvonen MJ et al. Indices of relative weight and obesity J Chron Dis 1972 25: 329–343

    Article  CAS  Google Scholar 

  23. CDC's Third National Health and Nutrition Examination Survey . Update: prevalence of overweight among children, adolescents and adults, United States, 1988–1994 MMWR 1997 46: 199–202

    Google Scholar 

  24. Stevens J, Cai J, Pamuk ER et al. The effect of age on the association between body-mass index and mortality New Engl J Med 1998 338: 1–7

    Article  CAS  Google Scholar 

  25. Mulder POM, Sleijfer DT, Willemse PHB et al. High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors Cancer Res 1989 49: 4654–4658

    CAS  PubMed  Google Scholar 

  26. Mills W, Chopra R, McMillian A et al. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma J Clin Oncol 1995 13: 588–595

    Article  CAS  Google Scholar 

  27. Kaplan EL, Meier P . Nonparametric estimation from incomplete observation J Am Stat Assoc 1958 53: 457–481

    Article  Google Scholar 

  28. Cox DR . Regression models and life tables JR Stat Soc (B) 1972 34: 187–220

    Google Scholar 

  29. Coldman AJ, Goldie JH . Impact of dose-intense chemotherapy on the development of permanent drug resistance Semin Oncol 1987 14: (Suppl. 4) 29–33

    CAS  PubMed  Google Scholar 

  30. Dunn SE, Kari FW, French J et al. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice Cancer Res 1997 57: 4667–4672

    CAS  PubMed  Google Scholar 

  31. Blay JY, Gomez F, Sebban C et al. The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial Blood 1998 92: 3562–3568

    CAS  PubMed  Google Scholar 

  32. Freedman AS, Neuberg D, Gribben JG et al. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission J Clin Oncol 1998 16: 13–18

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the medical staff and nurses of the Divisione Universitaria di Ematologia, of the Centro Dipartimentale Trapianto Midollo and of the Blood Bank, S Giovanni Hospital, Torino, Italy. This work was supported in part by Consiglio Nazionale delle Ricerche, Rome, Italy (special project ACRO, grant No. 96.00742.PF39 to TC and No. 96.00615.PF39 to AP) and by Associazione Italiana Ricerca sul Cancro, Milan, Italy.

Author information

Author notes

  1. P Corradini

    Present address: Unità Trapianto Midollo, H San Raffaele, Via Olgettina 60, Milano, 20132, Italy

Authors and Affiliations

  1. Dipartimento di Medicina e Oncologia Sperimentale, Divisione Universitaria di Ematologia, Italy

    C Tarella, D Caracciolo, P Gavarotti, C Argentino, F Zallio, P Corradini & A Pileri

  2. Anatomia Istologia Patologica II, Torino, Italy

    D Novero

  3. Servizio di Epidemiologia dei Tumori, Azienda Ospedaliera S Giovanni Battista, Torino, Italy

    C Magnani

Authors
  1. C Tarella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Caracciolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Gavarotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Argentino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F Zallio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P Corradini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D Novero
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C Magnani
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A Pileri
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tarella, C., Caracciolo, D., Gavarotti, P. et al. Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft. Bone Marrow Transplant 26, 1185–1191 (2000). https://doi.org/10.1038/sj.bmt.1702692

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702692

Keywords

This article is cited by

Search

Advanced search

Quick links